Comparable stake leader
Soleus Capital Master Fund, L.P.
SEC ownership of RIGEL PHARMACEUTICALS INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001034842.
Disclosed value leader
Soleus Capital Master Fund, L.P.
Comparable rows
50/50
Latest evidence
30 Jun 2026
- Public ticker
- RIGL on Nasdaq
- Parsed ownership sources
-
13D/G, 13F, and 3/4/5
Source: Parsed SEC ownership filingsUse: Compare filing families carefully
- Largest SEC-reported holder
-
Soleus Capital Master Fund, L.P.
Ranking: Comparable ownership first, then disclosed value
- Comparable ownership rows
-
50 of 50
Meaning: Rows with safely comparable ownership %
- Latest 13D/G holder
-
Soleus Capital Master Fund, L.P.
Source: Latest parsed Schedule 13D/G stake
- Latest parsed ownership date
-
30 Jun 2026
Freshness: Most recent filing date in this holder set
- Issuer CIK
- 0001034842
- Issuer location
- South San Francisco, CA
Ownership snapshot
CIK-linked ownership evidence from parsed SEC filings.
3 signals
Issuer
Names, identifiers, and filing context for this profile.
2 identity fields
Ownership snapshot
Top shareholders of RIGEL PHARMACEUTICALS INC (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Soleus Capital Master Fun...
Disclosed value leader
Soleus Capital Master Fun...
Comparable rows
50/50
Latest evidence
30 Jun 2026
13D/G
13F
3/4/5
Lead comparable stake: 9.9%
13D/G row: Soleus Capital Master Fund, L.P.
Showing 1-8 of 50 holder rows.
Quick read
Soleus Capital Master Fund, L.P. leads the comparable SEC ownership view at 9.9%.
50 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Soleus Capital Master Fund, L.P.'s linked filing trail.
Comparable ownership
Top 5
Soleus Capital Master Fund, L.P.
9.9%
ARMISTICE CAPITAL, LLC
9%
BlackRock, Inc.
7.7%
STATE STREET CORP
6%
MORGAN STANLEY
0.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-8 of 50 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Soleus Capital Master Fund, L.P. |
13D/G
|
9.9%
|
$76,136,715
1,843,504 shares
|
+$36,153,855 | 30 Jun 2026 |
| ARMISTICE CAPITAL, LLC |
13D/G
13F
Company
|
9%
|
$69,053,600
1,672,000 shares
|
+$16,189,600 | 30 Jun 2026 |
| BlackRock, Inc. |
13F
13D/G
Company
|
7.7%
from 13D/G
|
$75,891,702
1,943,334 shares
mixed-class rows
|
— | 30 Jun 2026 |
| STATE STREET CORP |
13D/G
13F
STATE STREET CORPORATION · Company
|
6%
|
$45,645,858
1,091,223 shares
|
$0 | 31 Dec 2025 |
| MORGAN STANLEY |
13F
13D/G
Company
|
0.7%
from 13D/G
|
$7,278,237
186,049 shares
|
— | 30 Jun 2026 |
| Invesco Ltd. |
13F
13D/G
Company
|
0.03%
from 13D/G
|
$1,133,149
28,966 shares
|
— | 30 Jun 2026 |
| Walter H. Moos |
3/4/5
Director
|
0.1%
|
$499,482
18,472 shares
|
-$145,440 | 15 May 2026 |
| Soleus Capital Management, L.P. |
13F
Company
|
9.9%
|
$72,117,876
1,843,504 shares
|
— | 30 Jun 2026 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider trading overview
Net insider flow leans to selling over the last 12 months. Net value: -$305,865.
Buys
$0
Insiders: 0
Sells
$305,865
Insiders: 2
Net
-$305,865
Shares: -9,000
Window
Last 12 months
4 rolling buckets
Buy value
Sell value
Shares: 0
Shares: 9,000
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 2,500 | $0 | $87,500 | -$87,500 |
| 3-6 | 0 | 2,500 | $0 | $72,925 | -$72,925 |
| 6-9 | 0 | 4,000 | $0 | $145,440 | -$145,440 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Insider holders from Forms 3/4/5
Showing 1-18 of 18 reporting-owner rows connected to RIGEL PHARMACEUTICALS INC. Open a relationship link for the CIK-to-CIK filing trail.
Rows
18
Largest Forms 3/4/5 holder
Raul R. Rodriguez
Net 12M change
-$305,865
Latest report
08 Jul 2026
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Raul R. Rodriguez | CEO, President, Director | $7,560,194 | Mixed | 17 Jun 2026 | ||
| Dean L. Schorno | EVP & Chief Financial Officer | $2,130,481 | Mixed | 17 Jun 2026 | ||
| David A. Santos | EVP, Chief Commercial Officer | $1,676,371 | Mixed | 17 Jun 2026 | ||
| Raymond J. Furey | EVP, GC, CCO & Corp Sec | $1,377,309 | Mixed | 17 Jun 2026 | ||
| Alison L. Hannah | EVP, Chief Medical Officer | $1,370,185 | Median | 08 Jul 2026 | ||
| Lisa Rojkjaer | EVP, Chief Medical Officer | $919,441 | Mixed | 17 Jun 2026 | ||
| Walter H. Moos | Director | $499,482 | -$145,440 | -23% | Mixed | 15 May 2026 |
| Anthony Gregg Lapointe | Director | $493,480 | Mixed | 15 May 2026 | ||
| Jane Wasman | Director | $493,480 | Mixed | 15 May 2026 | ||
| Kamil Ali-Jackson | Director | $354,375 | -$160,425 | -31% | Filing P/S | 22 Jun 2026 |
| Mark W. Frohlich | Director | $189,280 | Mixed | 15 May 2026 | ||
| Michael Patrick Miller | Director | $160,536 | Mixed | 15 May 2026 | ||
| Gary A. Lyons | Director | $131,250 | Mixed | 26 May 2023 | ||
| Wolfgang Dummer | Evp & Cmo | $126,803 | Mixed | 02 Feb 2023 | ||
| Brian L. Kotzin | Director | $114,000 | Mixed | 25 May 2024 | ||
| Bradford S. Goodwin | Director | $61,250 | Mixed | 19 May 2021 | ||
| Keith Katkin | Director | $43,750 | Mixed | 19 May 2021 | ||
| Dolly Vance | EVP Corp. Affairs, G.C., Sect. | Mixed | 14 Sep 2022 |
Recent insider transactions for RIGEL PHARMACEUTICALS INC
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Alison L. Hannah | RIGL | Common Stock | Award | 229.6% | 24,400 | 35,025 | 08 Jul 2026 | Direct | ||
| Kamil Ali-Jackson | RIGL | Common Stock | Sale | -19.8% | $87,500 | $35.00 | -2,500 | 10,125 | 22 Jun 2026 | Direct |
| Raymond J. Furey | RIGL | Employee Stock Option (right to buy) | Award | 7,394 | 7,394 | 17 Jun 2026 | Direct | |||
| Lisa Rojkjaer | RIGL | Employee Stock Option (right to buy) | Award | 16,769 | 9,375 | 17 Jun 2026 | Direct | |||
| Raul R. Rodriguez | RIGL | Employee Stock Option (right to buy) | Award | 31,700 | 31,700 | 17 Jun 2026 | Direct | |||
| David A. Santos | RIGL | Employee Stock Option (right to buy) | Award | 7,394 | 7,394 | 17 Jun 2026 | Direct | |||
| Dean L. Schorno | RIGL | Employee Stock Option (right to buy) | Award | 7,394 | 7,394 | 17 Jun 2026 | Direct | |||
| Dean L. Schorno | RIGL | Common Stock | Tax liability | -1.16% | -928 | 78,790 | 01 Jun 2026 | Direct | ||
| Dean L. Schorno | RIGL | Common Stock | Options Exercise | 4.43% | 3,381 | 79,718 | 01 Jun 2026 | Direct | ||
| Dean L. Schorno | RIGL | Employee Stock Option (right to buy) | Options Exercise | -26% | -3,381 | 9,632 | 01 Jun 2026 | Direct | ||
| David A. Santos | RIGL | Common Stock | Tax liability | -1.39% | -874 | 61,996 | 01 Jun 2026 | Direct | ||
| Lisa Rojkjaer | RIGL | Common Stock | Tax liability | -2.44% | -850 | 34,003 | 01 Jun 2026 | Direct | ||
| Raul R. Rodriguez | RIGL | Common Stock | Tax liability | -0.86% | -2,424 | 279,593 | 01 Jun 2026 | Direct | ||
| Raymond J. Furey | RIGL | Common Stock | Tax liability | -1.69% | -877 | 50,936 | 01 Jun 2026 | Direct | ||
| Kamil Ali-Jackson | RIGL | Common Stock | Sale | -16.5% | $72,925 | $29.17 | -2,500 | 12,625 | 26 May 2026 | Direct |
| Jane Wasman | RIGL | Common Stock | Award | 46% | 5,750 | 18,250 | 15 May 2026 | Direct | ||
| Walter H. Moos | RIGL | Common Stock | Award | 45.2% | 5,750 | 18,472 | 15 May 2026 | Direct | ||
| Michael Patrick Miller | RIGL | Common Stock | Award | 3074.9% | 5,750 | 5,937 | 15 May 2026 | Direct | ||
| Anthony Gregg Lapointe | RIGL | Common Stock | Award | 46% | 5,750 | 18,250 | 15 May 2026 | Direct | ||
| Alison L. Hannah | RIGL | Common Stock | Award | 54.1% | 5,750 | 16,375 | 15 May 2026 | Direct | ||
| Mark W. Frohlich | RIGL | Common Stock | Award | 460% | 5,750 | 7,000 | 15 May 2026 | Direct | ||
| Kamil Ali-Jackson | RIGL | Common Stock | Award | 61.3% | 5,750 | 15,125 | 15 May 2026 | Direct | ||
| Walter H. Moos | RIGL | Common Stock | Sale | -23.9% | $145,440 | $36.36 | -4,000 | 12,722 | 20 Feb 2026 | Direct |
| Walter H. Moos | RIGL | Common Stock | Options Exercise | 31.4% | 4,000 | 16,722 | 20 Feb 2026 | Direct | ||
| Walter H. Moos | RIGL | Stock Option (right to buy) | Options Exercise | -100% | -4,000 | 0 | 20 Feb 2026 | Direct | ||
| Raymond J. Furey | RIGL | Common Stock | Award | 60.3% | 19,497 | 51,813 | 17 Feb 2026 | Direct | ||
| Raul R. Rodriguez | RIGL | Common Stock | Award | 23.6% | 53,915 | 282,017 | 17 Feb 2026 | Direct | ||
| Lisa Rojkjaer | RIGL | Common Stock | Award | 118.4% | 18,894 | 34,853 | 17 Feb 2026 | Direct | ||
| David A. Santos | RIGL | Common Stock | Award | 44.7% | 19,430 | 62,870 | 17 Feb 2026 | Direct | ||
| Dean L. Schorno | RIGL | Common Stock | Award | 37% | 20,636 | 76,337 | 17 Feb 2026 | Direct | ||
| Dean L. Schorno | RIGL | Common Stock | Tax liability | -5.99% | -3,546 | 55,701 | 10 Feb 2026 | Direct | ||
| Raymond J. Furey | RIGL | Common Stock | Tax liability | -9.89% | -3,546 | 32,316 | 10 Feb 2026 | Direct | ||
| David A. Santos | RIGL | Common Stock | Tax liability | -7.55% | -3,546 | 43,440 | 10 Feb 2026 | Direct | ||
| Raul R. Rodriguez | RIGL | Common Stock | Tax liability | -3.23% | -7,607 | 228,102 | 10 Feb 2026 | Direct | ||
| Lisa Rojkjaer | RIGL | Common Stock | Tax liability | -19.1% | -3,758 | 15,959 | 10 Feb 2026 | Direct | ||
| David A. Santos | RIGL | Common Stock | Tax liability | -10.8% | -5,718 | 46,986 | 02 Feb 2026 | Direct | ||
| Dean L. Schorno | RIGL | Common Stock | Tax liability | -8.48% | -5,488 | 59,247 | 02 Feb 2026 | Direct | ||
| Raymond J. Furey | RIGL | Common Stock | Tax liability | -9.96% | -3,968 | 35,862 | 02 Feb 2026 | Direct | ||
| Raul R. Rodriguez | RIGL | Common Stock | Tax liability | -5.65% | -14,110 | 235,709 | 02 Feb 2026 | Direct | ||
| Michael Patrick Miller | RIGL | Stock Option (right to buy) | Award | 12,000 | 12,000 | 01 Feb 2026 | Direct | |||
| Raul R. Rodriguez | RIGL | Common Stock | Tax liability | -22.4% | -70,635 | 245,243 | 26 Jan 2026 | Direct | ||
| Raul R. Rodriguez | RIGL | Common Stock | Options Exercise | 39% | 80,000 | 285,243 | 26 Jan 2026 | Direct | ||
| Raul R. Rodriguez | RIGL | Employee Stock Option (right to buy) | Options Exercise | -100% | -80,000 | 0 | 26 Jan 2026 | Direct | ||
| Dean L. Schorno | RIGL | Common Stock | Options Exercise | 11.3% | 6,500 | 64,235 | 22 Dec 2025 | Direct | ||
| Dean L. Schorno | RIGL | Employee Stock Option (right to buy) | Options Exercise | -37.5% | -6,500 | 10,832 | 22 Dec 2025 | Direct | ||
| Dean L. Schorno | RIGL | Employee Stock Option (right to buy) | Award | 7,394 | 7,394 | 15 Sep 2025 | Direct | |||
| David A. Santos | RIGL | Employee Stock Option (right to buy) | Award | 7,394 | 7,394 | 15 Sep 2025 | Direct | |||
| Lisa Rojkjaer | RIGL | Employee Stock Option (right to buy) | Award | 7,394 | 7,394 | 15 Sep 2025 | Direct | |||
| Raymond J. Furey | RIGL | Employee Stock Option (right to buy) | Award | 7,394 | 7,394 | 15 Sep 2025 | Direct | |||
| Raul R. Rodriguez | RIGL | Employee Stock Option (right to buy) | Award | 31,700 | 31,700 | 15 Sep 2025 | Direct |
* marks a reported price that did not pass the local price check.